The benefits and risks of using a levonorgestrel-releasing intrauterine system for contraception
- 1 March 2012
- journal article
- review article
- Published by Elsevier BV in Contraception
- Vol. 85 (3), 224-234
- https://doi.org/10.1016/j.contraception.2011.08.003
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- Effects of the levonorgestrel-releasing intrauterine system on cervical mucus quality and sperm penetrabilityContraception, 2010
- Serum levonorgestrel levels and endometrial thickness during extended use of the levonorgestrel-releasing intrauterine systemContraception, 2009
- The levonorgestrel-releasing intrauterine system (LNG-IUS) in HIV-infected women—effects on bleeding patterns, ovarian function and genital shedding of HIVHuman Reproduction, 2006
- Serum and peritoneal fluid levels of levonorgestrel in women with endometriosis who were treated with an intrauterine contraceptive device containing levonorgestrelFertility and Sterility, 2005
- Benefit-Risk Assessment of the Levonorgestrel Intrauterine System in ContraceptionDrug Safety, 2004
- Morphological and functional changes in human endometrium following intrauterine levonorgestrel deliveryHuman Reproduction, 2000
- The ultrastructure of human endometrium is altered by administration of intrauterine levonorgestrelHuman Reproduction, 1998
- Serum SHBG levels during normal menstrual cycle and after insertion of levonorgestrel-releasing IUDAdvances in Contraception, 1992
- Levonorgestrel-Releasing Intrauterine DeviceAnnals of Medicine, 1990
- Endometrial Morphology During Long-Term Use of Levonorgestrel-Releasing Intrauterine DevicesInternational Journal of Gynecological Pathology, 1986